Qualitative rather than quantitative changes are hallmarks of fibroblasts in bleomycin-induced pulmonary fibrosis.

[1]  R. Mason,et al.  Efficient and rapid isolation and purification of mouse alveolar type II epithelial cells , 2012, Experimental lung research.

[2]  C. Barkauskas,et al.  Pulmonary fibrosis: patterns and perpetrators. , 2012, The Journal of clinical investigation.

[3]  A. Anwar,et al.  Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[4]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[5]  A. Borczuk,et al.  Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury. , 2012, The American journal of pathology.

[6]  Moisés Selman,et al.  Idiopathic pulmonary fibrosis , 2011, The Lancet.

[7]  Michael J. Cronce,et al.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.

[8]  V. Aidinis,et al.  Modeling pulmonary fibrosis with bleomycin , 2011, Current opinion in pulmonary medicine.

[9]  O. Shupliakov,et al.  A Pericyte Origin of Spinal Cord Scar Tissue , 2011, Science.

[10]  Thomas A. Wynn,et al.  Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.

[11]  T. Uede.  Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases , 2011, Pathology international.

[12]  Y. Tabata,et al.  Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. , 2011, The Journal of investigative dermatology.

[13]  A. Wells,et al.  An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor. , 2011, American journal of respiratory and critical care medicine.

[14]  C. Shimbori,et al.  Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice , 2010, Experimental lung research.

[15]  T. Wynn,et al.  Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent , 2010, The Journal of experimental medicine.

[16]  A. McMahon,et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.

[17]  Y. Inagaki,et al.  Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. , 2009, Gastroenterology.

[18]  A. Miyawaki,et al.  Time-lapse observation of cellular function with fluorescent probe reveals novel CTL-target cell interactions. , 2009, International immunology.

[19]  E. Neilson,et al.  Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. , 2009, American journal of respiratory and critical care medicine.

[20]  V. Aidinis,et al.  Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis , 2009, Thorax.

[21]  P. Wolters,et al.  Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. , 2008, The Journal of clinical investigation.

[22]  D. Rifkin,et al.  Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin. , 2009, The American journal of pathology.

[23]  D. Brenner,et al.  Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. , 2008, The American journal of pathology.

[24]  T. Colby,et al.  Knowns and unknowns of the alveolus. , 2008, Proceedings of the American Thoracic Society.

[25]  R. Nho,et al.  Polymerized Collagen Inhibits Fibroblast Proliferation via a Mechanism Involving the Formation of a β1 Integrin-Protein Phosphatase 2A-Tuberous Sclerosis Complex 2 Complex That Suppresses S6K1 Activity* , 2008, Journal of Biological Chemistry.

[26]  Adeline Koh,et al.  Osteopontin Expression Is Required for Myofibroblast Differentiation , 2008, Circulation research.

[27]  Atsushi Miyawaki,et al.  Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.

[28]  T. Shaw,et al.  Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring , 2008, The Journal of experimental medicine.

[29]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[30]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[31]  Giulio Gabbiani,et al.  The myofibroblast: one function, multiple origins. , 2007, The American journal of pathology.

[32]  Takeshi Fukuda,et al.  Gefitinib prevents bleomycin-induced lung fibrosis in mice. , 2006, American journal of respiratory and critical care medicine.

[33]  A. O’Regan,et al.  Interleukin‐1β induces osteopontin expression in pulmonary fibroblasts , 2006, Journal of cellular biochemistry.

[34]  Naftali Kaminski,et al.  Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.

[35]  R. Homer,et al.  Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis. , 2005, American journal of respiratory cell and molecular biology.

[36]  M. Burdick,et al.  Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. , 2004, The Journal of clinical investigation.

[37]  A. Miyawaki,et al.  A high-throughput method for development of FRET-based indicators for proteolysis. , 2004, Biochemical and biophysical research communications.

[38]  L. Liaw,et al.  Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[39]  S. Phan,et al.  Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.

[40]  C. Murry,et al.  Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. , 2003, The American journal of pathology.

[41]  Takeharu Nagai,et al.  Spatio-temporal activation of caspase revealed by indicator that is insensitive to environmental effects , 2003, The Journal of cell biology.

[42]  R. Knuechel,et al.  Three-dimensional tissue structure affects sensitivity of fibroblasts to TGF-β1 , 2003 .

[43]  D. Abraham,et al.  Identification of the Key Regions within the Mouse Pro-α2(I) Collagen Gene Far-upstream Enhancer* , 2002, The Journal of Biological Chemistry.

[44]  M. Selman,et al.  Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. , 2001, American journal of respiratory cell and molecular biology.

[45]  W. Foster,et al.  Methodology for the measurement of mucociliary function in the mouse by scintigraphy. , 2001, Journal of applied physiology.

[46]  M. Fujita,et al.  Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[47]  David G. Morris,et al.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Rekhter,et al.  Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. , 1994, The American journal of pathology.

[49]  C. Chaponnier,et al.  Cytoskeletal features of alveolar myofibroblasts and pericytes in normal human and rat lung. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[50]  M. Kitaichi,et al.  Proliferative characteristics of fibroblast lines derived from open lung biopsy specimens of patients with IPF (UIP). , 1992, Chest.

[51]  Y. Fukuda,et al.  Cell Proliferation during the Process of Bleomycin‐induced Pulmonary Fibrosis in Rats , 1990, Acta pathologica japonica.

[52]  J. Myers,et al.  Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. , 1988, Chest.

[53]  P. Moseley,et al.  Augmentation of fibroblast proliferation by bleomycin. , 1986, The Journal of clinical investigation.

[54]  V. Ferrans,et al.  Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. , 1985, The American journal of pathology.